Floatz logo

xw003

Obstructive Sleep Apnea Syndrome

Hangzhou Sciwind Biosciences Co., Ltd.protein_peptidePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Obstructive Sleep Apnea Syndrome cohort.

Asset / SponsorPhaseRating
Adalimumab
Innovaderm Research Inc.
Phase 4BB
MELATONIN
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 4BB
Liraglutide
St Vincent's University Hospital, Ireland
Phase 3BB
Orforglipron
Eli Lilly and Company
Phase 3B
Eloralintide
Eli Lilly and Company
Phase 3B

View all 16 →

Same molecule, other indications

xw003 is also rated in:

obesity disorderDormant
BB
Indicative ·
64 / 100
View asset →
obesity disorderDormant
B
Indicative ·
61 / 100
View asset →
Type 2 Diabetes MellitusDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →